Protai
Sector: Healthcare & Life Sciences
About Protai
As chief scientific officer, he provides focused leadership for the institution’s diverse scientific and clinical research faculty, championing innovation and team science, and fostering strong partnerships with the cancer research community worldwide.
Products
AIMS™ Platform
Maps disease specific protein state & function to maximize therapy, integrating proteomics and structural AI to identify innovative target strategies and design novel drugs. Protai’s AIMS™ platform maps cell type protein states to define a precise, context-specific mechanism-of-action. This allows selective inhibition of disease-relevant activity while preserving beneficial functions, leading to smarter targeting and better outcomes. AIMS™ utilizes structural proteomics (XL-MS, HDX-MS) to determine the disease-specific protein state conformation. The conformation is then modeled using structural AI and simulations to pinpoint pockets that achieve the desired mechanism-of-action. Computational drug design, enables discovery of modulators for redefined targets in cancer and autoimmune diseases.